The advent of molecular testing has resulted in the ability to provide a new level of information that can assist in better treatment options. Pathology, Inc. offers the latest molecular technologies, thus providing comprehensive diagnostic and prognostic information for better patient care. Our goal is to assist physicians in providing quick and complete answers to their patients’ questions resulting in better treatment planning.

Molecular services that we provide include:



  • HER2 Neu
    • FISH (PathVysion™ HER-2)

Colorectal Cancer:



  • UroVysion™ FISH
    • FISH-based test for screening and monitoring of bladder cancer

For more information:

Connect With Us!

© 2016 Pathology, Inc.